SCYNEXIS
SCYX
#10060
Rank
NZ$47.41 M
Marketcap
NZ$1.13
Share price
1.23%
Change (1 day)
-44.42%
Change (1 year)

Market capitalization of SCYNEXIS (SCYX)

Market cap: NZ$47.41 Million

As of January 2026 SCYNEXIS has a market cap of NZ$47.41 Million. This makes SCYNEXIS the world's 10060th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of SCYNEXIS from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$47.41 M11.45%
2025NZ$42.54 M-36.72%
2024NZ$67.22 M-48.76%
2023NZ$0.13 B63.51%
2022NZ$80.24 M-62.48%
2021NZ$0.21 B4.64%
2020NZ$0.20 B55.3%
2019NZ$0.13 B282.08%
2018NZ$34.45 M-63.07%
2017NZ$93.29 M-15.56%
2016NZ$0.11 B-12.43%
2015NZ$0.12 B16.37%
2014NZ$0.10 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of SCYNEXIS was reported to be:

NZ$47.41 Million
by Nasdaq info icon info icon
NZ$47.41 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Galmed Pharmaceuticals
GLMD
NZ$7.34 M-84.51%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
KemPharm
KMPH
NZ$0.34 B 634.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
NZ$20.02 B 42,141.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$4.84 B 10,128.70%๐Ÿ‡บ๐Ÿ‡ธ USA